ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year’s Resolutions

A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests that societal pressures significantly influence women’s decisions to set New Year’s resolutions for 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250117894667/en/

New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year’s Resolutions (Graphic: Business Wire)

New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year’s Resolutions (Graphic: Business Wire)

While Ditch New Year’s Resolution Day (Jan. 17) is thought to be the day when a large number of people abandon their goals for the new year, women are determined to achieve their 2025 resolutions which mainly focus on health and wellness.

Key findings from the survey include:

  • Impact of Societal Pressures: Almost two-third (63%) of women acknowledge that societal pressures—influence from family, friends, social media or broader cultural expectations— have at least a small impact on their decision to set a New Year’s resolution. For GenZers, four in five (79%) are influenced by societal pressure. This highlights the external influences that can shape personal health goals, often leading to setting goals which may be not sustainable or attainable.
  • Commitment to Health Goals: Despite these pressures, a remarkable 87% of women express commitment to their New Year’s resolutions. In the past, a lack of motivation (45%) as well as financial difficulties (33%) have been the biggest barriers for women to complete their resolutions.
  • Health and Wellness Focus: Women report a strong desire for self-care (70%) and a focus on health and wellness (62%) among their priorities. Within those categories, about half of women (49%) surveyed want to focus more specifically on mental health or a healthy diet (44%).
  • Multivitamin Adoption: In alignment with their health goals, 41% plan or consider to incorporate a multivitamin or supplement into their routine as part of their New Year's resolution. Currently, 39% already take a multivitamin.

“Health and wellness goals should reflect women’s unique, personal aspirations rather than societal pressures,” said Lisa Perez, General Manager and VP Marketing Nutritionals at Bayer. “As everyone is different, so should be their goals and nutritional support. At One A Day®, we provide specially formulated multivitamins for different genders, ages and health goals to support everyone in achieving their resolutions.”

Bayer, the maker of One A Day®, is one of the U.S. leading life sciences companies at the intersection of health and nutrition, offering many self-care solutions that are empowering consumers to take charge of their personal health. For more information about One A Day®, visit oneaday.com.

Research Methodology

This survey was conducted online within the United States by Morning Consult on behalf of Bayer from December 9 – December 11, 2024, among 2,257 U.S. women ages 18-55. Survey respondents were weighted based on U.S. Census data for age, race, gender, and educational attainment. For this study, the total sample data is accurate to within +/- 2 percentage points.

About One A Day®

One A Day® is a multivitamin and supplement brand offering specially formulated multivitamins and supplements for many members of the family. From prenatal to 65+, One A Day® offers products for different ages, genders and health goals. The portfolio includes tablet, softgel, capsule, and gummy products. One A Day® products are available at most major drugstores and retailers nationwide. For more information on One A Day® please visit www.oneaday.com or follow us on Facebook or Instagram.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission Health for all, Hunger for none, the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.32
-4.68 (-1.84%)
AAPL  270.04
+0.99 (0.37%)
AMD  250.05
-9.60 (-3.70%)
BAC  53.54
-0.02 (-0.04%)
GOOG  278.06
-6.06 (-2.13%)
META  627.32
-10.39 (-1.63%)
MSFT  514.33
-2.70 (-0.52%)
NVDA  198.69
-8.19 (-3.96%)
ORCL  248.17
-9.68 (-3.75%)
TSLA  444.26
-24.11 (-5.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.